102 research outputs found
Maternal HIV infection is an important health determinant in non-HIV-infected infants
OBJECTIVE: To assess morbidity and mortality in HIV-exposed
uninfected (HEU) children to help guiding appropriate clinical
care and effective preventive interventions. DESIGN: This is a
longitudinal study comparing two cohorts of children; one born
to HIV-infected women and the other born to HIV-uninfected
women. METHODS: We have analyzed prospectively obtained
information on nutritional status, morbidity and mortality from
966 HEU and 909 HIV-unexposed infants followed up until their
first 18 months of life at a referral health facility in
southern Mozambique. Determinants for adverse health outcomes in
HEU children were also assessed using multivariate logistic
regression. RESULTS: Increased incidence of hospital admissions
(P = 0.0015), shorter survival in the first 18 months of life (P
= 0.0510) and moderate and severe malnutrition (P = 0.0006 and
0.0014, respectively) were observed among HEU children compared
with HIV-unexposed children. Incidence of outpatient attendance
in HEU children was associated with being men, older age and the
mother being on antiretroviral treatment. Among HEU children,
those who were never breastfed, or who were weaned or were
partially breastfed, had an increased incidence of hospital
admissions compared with children who were exclusively
breastfed. CONCLUSION: Maternal HIV infection has important
health consequences in non-HIV-infected children. As the
prevalence of HIV-infected pregnant women is maintained and the
proportion of HIV-infected children declines because of the
scale-up of antiretroviral treatment during pregnancy and
breastfeeding, more focus should be given to the health needs of
HEU children to ensure that the post-2015 sustainable
development goals are met
Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out
INTRODUCTION: The HIV epidemic is concentrated in sub-Saharan
Africa. However, limited information exists on its impact on
women and infant's health since the introduction of
antiretroviral drugs in this region, where health resources are
often scarce. METHODS: The effect of HIV infection on maternal
health, birth outcomes and infant health was analysed in two
contemporary cohorts of HIV-uninfected and HIV-infected pregnant
women from southern Mozambique. Pregnant women attending the
first antenatal care visit were followed until one month after
delivery. Antiretroviral therapy was administered based on CD4+T
cell count and clinical stage. Maternal and neonatal morbidity
and mortality, as well as pregnancy outcomes were assessed by
mother's HIV status. RESULTS: A total of 1183 HIV-uninfected and
561 HIV-infected pregnant women were enrolled. HIV-infected
women were more likely to have anaemia both at the first
antenatal care visit and at delivery than HIV-uninfected women
(71.5% versus 54.8% and 49.4% versus 40.6%, respectively,
p<0.001). Incidence of hospital admissions during pregnancy
was increased among HIV-infected women (RR, 2.04, [95%CI, 1.45;
2.86]; p<0.001). At delivery, 21% of HIV-infected women
reported being on antiretroviral therapy, and 70% having
received antiretroviral drugs for prevention of mother to child
transmission of HIV. The risk of stillbirths was doubled in
HIV-infected women (RR, 2.16 [95%CI 1.17; 3.96], p = 0.013).
Foetal anaemia was also increased among infants born to
HIV-infected women (10.6% versus 7.3%, p = 0.022). No
differences were found in mean birth weight, malaria,
prematurity and maternal and neonatal deaths between groups.
CONCLUSIONS: HIV infection continues to be associated with
significant maternal morbidity and poor neonatal health
outcomes. Efforts should urgently be made to identify the
barriers that impede improvements on the devastating effects of
HIV in African women and their infants. TRIAL REGISTRATION:
ClinicalTrials.gov NCT 00811421
Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens
Background
Pregnant women exposed to Plasmodium falciparum generate antibodies against VAR2CSA, the parasite protein that mediates adhesion of infected erythrocytes to the placenta. There is a need of high-throughput tools to determine the fine specificity of these antibodies that can be used to identify immune correlates of protection and exposure. Here we aimed at developing a multiplex-immunoassay to detect antibodies against VAR2CSA antigens.
Methods and findings
We constructed two multiplex-bead arrays, one composed of 3 VAR2CSA recombinant-domains (DBL3X, DBL5Æ and DBL6Æ) and another composed of 46 new peptides covering VAR2CSA conserved and semi-conserved regions. IgG reactivity was similar in multiplexed and singleplexed determinations (Pearson correlation, protein array: R2 = 0.99 and peptide array: R2 = 0.87). IgG recognition of 25 out of 46 peptides and all recombinant-domains was higher in pregnant Mozambican women (n = 106) than in Mozambican men (n = 102) and Spanish individuals (n = 101; p<0.05). Agreement of IgG levels detected in cryopreserved plasma and in elutions from dried blood spots was good after exclusion of inappropriate filter papers. Under heterogeneous levels of exposure to malaria, similar seropositivity cutoffs were obtained using finite mixture models applied to antibodies measured on pregnant Mozambican women and average of antibodies measured on pregnant Spanish women never exposed to malaria. The application of the multiplex-bead array developed here, allowed the assessment of higher IgG levels and seroprevalences against VAR2CSA-derived antigens in women pregnant during 2003â2005 than during 2010â2012, in accordance with the levels of malaria transmission reported for these years in Mozambique.
Conclusions
The multiplex bead-based immunoassay to detect antibodies against selected 25 VAR2CSA new-peptides and recombinant-domains was successfully implemented. Analysis of field samples showed that responses were specific among pregnant women and dependent on the level of exposure to malaria. This platform provides a high-throughput approach to investigating correlates of protection and identifying serological markers of exposure for malaria in pregnancy
Association of Maternal Factors and HIV Infection With Innate Cytokine Responses of Delivering Mothers and Newborns in Mozambique
Maternal factors and exposure to pathogens have an impact on infant health. For instance, HIV exposed but uninfected infants have higher morbidity and mortality than HIV unexposed infants. Innate responses are the first line of defense and orchestrate the subsequent adaptive immune response and are especially relevant in newborns. To determine the association of maternal HIV infection with maternal and newborn innate immunity we analyzed the cytokine responses upon pattern recognition receptor (PRR) stimulations in the triad of maternal peripheral and placental blood as well as in cord blood in a cohort of mother-infant pairs from southern Mozambique. A total of 48 women (35 HIV-uninfected and 13 HIV-infected) were included. Women and infant innate responses positively correlated with each other. Age, gravidity and sex of the fetus had some associations with spontaneous production of cytokines in the maternal peripheral blood. HIV-infected women not receiving antiretroviral therapy (ART) before pregnancy showed decreased IL-8 and IL-6 PRR responses in peripheral blood compared to those HIV-uninfected, and PRR hyporesponsiveness for IL-8 was also found in the corresponding infant's cord blood. HIV infection had a greater impact on placental blood responses, with significantly increased pro-inflammatory, T H 1 and T H 17 PRR responses in HIV-infected women not receiving ART before pregnancy compared to HIV-uninfected women. In conclusion, innate response of the mother and her newborn was altered by HIV infection in the women who did not receive ART before pregnancy. As these responses could be related to birth outcomes, targeted innate immune modulation could improve maternal and newborn health
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique
BACKGROUND: Few data on HIV resistance in pregnancy are
available from Mozambique, one of the countries with the highest
HIV toll worldwide. Understanding the patterns of HIV drug
resistance in pregnant women might help in tailoring optimal
regimens for prevention of mother to child transmission of HIV
(pMTCT) and antenatal care. OBJECTIVES: To describe the
frequency and characteristics of HIV drug resistance mutations
(HIVDRM) in pregnant women with virological failure at delivery,
despite pMTCT or antiretroviral therapy (ART). METHODS: Samples
from HIV-infected pregnant women from a rural area in southern
Mozambique were analysed. Only women with HIV-1 RNA >400c/mL
at delivery were included in the analysis. HIVDRM were
determined using MiSeq(R) (detection threshold 1%) at the first
antenatal care (ANC) visit and at the time of delivery. RESULTS:
Ninety and 60 samples were available at the first ANC visit and
delivery, respectively. At first ANC, 97% of the women had HIV-1
RNA>400c/mL, 39% had CD4+ counts <350 c/mm3 and 30% were
previously not on ART. Thirteen women (14%) had at least one
HIVDRM of whom 70% were not on previous ART. Eight women (13%)
had at least one HIVDRM at delivery. Out of 37 women with data
available from the two time points, 8 (21%) developed at least
one new HIVDRM during pMTCT or ART. Twenty seven per cent
(53/191), 32% (44/138) and 100% (5/5) of the mutations that were
present at enrolment, delivery and that emerged during
pregnancy, respectively, were minority mutations (frequency
<20%). CONCLUSIONS: Even with ultrasensitive HIV-1
genotyping, less than 20% of women with detectable viremia at
delivery had HIVDRM before initiating pMTCT or ART. This
suggests that factors other than pre-existing resistance, such
as lack of adherence or interruptions of the ANC chain, are also
relevant to explain lack of virological suppression at the time
of delivery in women receiving antiretrovirals drugs during
pregnancy
Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trial
Background: At times, ultrasound is not readily available in low resource countries in Africa for accurate determination of gestational age, so using alternative methods is pivotal during pregnancy. These assessments are used to aid the risk analysis for an infant and management strategies for premature delivery, if necessary. Currently, date of last menstrual period, fundal height measurements, and the New Ballard Score are commonly used in resource-limited settings. However, concordance of these measures is unknown for sub-Saharan Africa. We obtained data from an open-label randomized controlled trial, to assess the concordance of these alternative assessment methods. The purpose of our study was to determine the agreement between these alternative methods when used in sub-Saharan African populations. Methods: A total of 4,390 pregnant women from Benin, Gabon, Mozambique and Tanzania were included in our analysis. The assessment methods compared were: 1) reported last menstrual period, 2) symphysis-fundal height measurement, and 3) the New Ballard Score. The Bland-Altman method and intraclass correlation coefficient (ICC) were used to test the degree of agreement. Survival range gestational age, used as an inclusion criterion for further analysis, was from 22 to 44 weeks. Findings:
Plots showed a lack of agreement between methods and the 95% limits of agreement too wide to be clinically useful. ICC = 0.25 indicated poor agreement. A post-hoc analysis, restricted from 32 to 42 weeks, was done to check for better agreement in this near-term population. The plots and ICC = 0.16 still confirmed poor agreement. Conclusion: The alternative assessments do not result in comparable outcomes and discrepancies are far beyond the clinically acceptable range. Last menstrual period should not be used as the only estimator of gestational age. In the absence of reliable early ultrasound, symphysis-fundal height measurements may be most useful during pregnancy for fetal risk assessment and the New Ballard Score after delivery as a confirmation of these estimations and for further neonatal management. However, promotion of portable ultrasound devices is required for accurate assessment of gestational age in sub-Sahara Africa
Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy.
BACKGROUND: Prevention of reinfection and resurgence is an integral component of the goal to eradicate malaria. However, the adverse effects of malaria resurgences are not known. METHODS: We assessed the prevalence of Plasmodium falciparum infection among 1819 Mozambican women who delivered infants between 2003 and 2012. We used microscopic and histologic examination and a quantitative polymerase-chain-reaction (qPCR) assay, as well as flow-cytometric analysis of IgG antibody responses against two parasite lines. RESULTS: Positive qPCR tests for P. falciparum decreased from 33% in 2003 to 2% in 2010 and increased to 6% in 2012, with antimalarial IgG antibody responses mirroring these trends. Parasite densities in peripheral blood on qPCR assay were higher in 2010-2012 (geometric mean [±SD], 409±1569 genomes per microliter) than in 2003-2005 (44±169 genomes per microliter, P=0.02), as were parasite densities in placental blood on histologic assessment (50±39% of infected erythrocytes vs. 4±6%, P<0.001). The malaria-associated reduction in maternal hemoglobin levels was larger in 2010-2012 (10.1±1.8 g per deciliter in infected women vs. 10.9±1.7 g per deciliter in uninfected women; mean difference, -0.82 g per deciliter; 95% confidence interval [CI], -1.39 to -0.25) than in 2003-2005 (10.5±1.1 g per deciliter vs. 10.6±1.5 g per deciliter; difference, -0.12 g per deciliter; 95% CI, -0.67 to 0.43), as was the reduction in birth weight (2863±440 g in women with past or chronic infections vs. 3070±482 g in uninfected women in 2010-2012; mean difference, -164.5 g; 95% CI, -289.7 to -39.4; and 2994±487 g vs. 3117±455 g in 2003-2005; difference, -44.8 g; 95% CI, -139.1 to 49.5). CONCLUSIONS: Antimalarial antibodies were reduced and the adverse consequences of P. falciparum infections were increased in pregnant women after 5 years of a decline in the prevalence of malaria. (Funded by Malaria Eradication Scientific Alliance and others.)
Causes and circumstances of maternal death:a secondary analysis of the Community-Level Interventions for (CLIP) trials cohort
BACKGROUND: Incomplete vital registration systems mean that causes of death during pregnancy and childbirth are poorly understood in low-income and middle-income countries. To inform global efforts to reduce maternal mortality, we compared physician review and computerised analysis of verbal autopsies (interpreting verbal autopsies [InterVA] software), to understand their agreement on maternal cause of death and circumstances of mortality categories (COMCATs) in the Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials. METHODS: The CLIP trials took place in India, Pakistan, and Mozambique, enrolling pregnant women aged 12â49 years between Nov 1, 2014, and Feb 28, 2017. 69â330 pregnant women were enrolled in 44 clusters (36â008 in the 22 intervention clusters and 33â322 in the 22 control clusters). In this secondary analysis of maternal deaths in CLIP, we included women who died in any of the 22 intervention clusters or 22 control clusters. Trained staff administered the WHO 2012 verbal autopsy after maternal deaths. Two physicians (and a third for consensus, if needed) reviewed trial surveillance data and verbal autopsies, and, in intervention clusters, community health worker-led visit data. They determined cause of death according to the WHO International Classification of Diseases-Maternal Mortality (ICD-MM). Verbal autopsies were also analysed by InterVA computer models (versions 4 and 5) to generate cause of death. COMCAT analysis was provided by InterVA-5 and, in India, by physician review of Maternal Newborn Health Registry data. Causes of death and COMCATs assigned by physician review, Inter-VA-4, and InterVA-5 were compared, with agreement assessed with Cohen's Îș coefficient. FINDINGS: Of 61â988 pregnancies with successful follow-up in the CLIP trials, 143 maternal deaths were reported (16 deaths in India, 105 in Pakistan, and 22 in Mozambique). The maternal death rate was 231 (95% CI 193â268) per 100â000 identified pregnancies. Most deaths were attributed to direct maternal causes (rather than indirect or undetermined causes as per ICD-MM classification), with fair to good agreement between physician review and InterVA-4 (Îș=0·56 [95% CI 0·43â0·66]) or InterVA-5 (Îș=0·44 [0·30â0·57]), and InterVA-4 and InterVA-5 (Îș=0·72 [0·60â0·84]). The top three causes of death were the same by physician review, InterVA-4, and InterVA-5 (ICD-MM categories obstetric haemorrhage, non-obstetric complications, and hypertensive disorders); however, attribution of individual patient deaths to obstetric haemorrhage varied more between methods (physician review, 38 [27%] deaths; InterVA-4, 69 [48%] deaths; and InterVA-5, 82 [57%] deaths), than did attribution to non-obstetric causes (physician review, 39 [27%] deaths; InterVA-4, 37 [26%] deaths; and InterVA-5, 28 [20%] deaths) or hypertensive disorders (physician review, 23 [16%] deaths; InterVA-4, 25 [17%] deaths; and InterVA-5, 24 [17%] deaths). Agreement for all nine ICD-MM categories was fair for physician review versus InterVA-4 (Îș=0·48 [0·38â0·58]), poor for physician review versus InterVA-5 (Îș=0·36 [0·27â0·46]), and good for InterVA-4 versus InterVA-5 (Îș=0·69 [0·59â0·79]). The most commonly assigned COMCATs by InterVA-5 were emergencies (68 [48%] of 143 deaths) and health systems (62 [43%] deaths), and by physician review (India only) were health systems (seven [44%] of 16 deaths) and inevitability (five [31%] deaths); agreement between InterVA-5 and physician review (India data only) was poor (Îș=0·04 [0·00â0·15]). INTERPRETATION: Our findings indicate that InterVA-5 is less accurate than InterVA-4 at ascertaining causes and circumstances of maternal death, when compared with physician review. Our results suggest a need to improve the next iteration of InterVA, and for researchers and clinicians to preferentially use InterVA-4 when recording maternal deaths. FUNDING: University of British Columbia (grantee of the Bill & Melinda Gates Foundation)
Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities.
BACKGROUND: Resistance and tolerance to Plasmodium falciparum can determine the progression of malaria disease. However, quantitative evidence of tolerance is still limited. We investigated variations in the adverse impact of P. falciparum infections among African pregnant women under different intensities of malaria transmission. METHODS: P. falciparum at delivery was assessed by microscopy, quantitative PCR (qPCR) and placental histology in 946 HIV-uninfected and 768 HIV-infected pregnant women from Benin, Gabon, Kenya and Mozambique. Resistance was defined by the proportion of submicroscopic infections and the levels of anti-parasite antibodies quantified by Luminex, and tolerance by the relationship of pregnancy outcomes with parasite densities at delivery. RESULTS: P. falciparum prevalence by qPCR in peripheral and/or placental blood of HIV-uninfected Mozambican, Gabonese and Beninese women at delivery was 6% (21/340), 11% (28/257) and 41% (143/349), respectively. The proportion of peripheral submicroscopic infections was higher in Benin (83%) than in Mozambique (60%) and Gabon (55%; Pâ=â0.033). Past or chronic placental P. falciparum infection was associated with an increased risk of preterm birth in Mozambican newborns (ORâ=â7.05, 95% CI 1.79 to 27.82). Microscopic infections were associated with reductions in haemoglobin levels at delivery among Mozambican women (-1.17Â g/dL, 95% CI -2.09 to -0.24) as well as with larger drops in haemoglobin levels from recruitment to delivery in Mozambican (-1.66Â g/dL, 95% CI -2.68 to -0.64) and Gabonese (-0.91Â g/dL, 95% CI -1.79 to -0.02) women. Doubling qPCR-peripheral parasite densities in Mozambican women were associated with decreases in haemoglobin levels at delivery (-0.16Â g/dL, 95% CI -0.29 to -0.02) and increases in the drop of haemoglobin levels (-0.29Â g/dL, 95% CI -0.44 to -0.14). Beninese women had higher anti-parasite IgGs than Mozambican women (Pâ<â0.001). No difference was found in the proportion of submicroscopic infections nor in the adverse impact of P. falciparum infections in HIV-infected women from Kenya (P. falciparum prevalence by qPCR: 9%, 32/351) and Mozambique (4%, 15/417). CONCLUSIONS: The lowest levels of resistance and tolerance in pregnant women from areas of low malaria transmission were accompanied by the largest adverse impact of P. falciparum infections. Exposure-dependent mechanisms developed by pregnant women to resist the infection and minimise pathology can reduce malaria-related adverse outcomes. Distinguishing both types of defences is important to understand how reductions in transmission can affect malaria disease. TRIAL REGISTRATION: ClinicalTrials.gov NCT00811421 . Registered 18 December 2008
Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study
Objectives: One of Africa's most important challenges is to improve maternal and neonatal health. The identification of groups at highest risk for adverse pregnancy outcomes is important for developing and implementing targeted prevention programmes. This study assessed whether young adolescent girls constitute a group at increased risk for adverse birth outcomes among pregnant women in sub-Saharan Africa.
Setting: Data were collected prospectively as part of a large randomised controlled clinical trial evaluating intermittent preventive treatment of malaria in pregnancy (NCT00811421âClinical Trials.gov), conducted between September 2009 and December 2013 in Benin, Gabon, Mozambique and Tanzania. Participants: Of 4749 participants, pregnancy outcomes were collected for 4388 deliveries with 4183 live births including 83 multiple gestations. Of 4100 mothers with a singleton live birth delivery, 24% (975/4100) were adolescents (â€19â
years of age) and 6% (248/4100) were aged â€16â
years. Primary and secondary outcome measures: Primary outcomes of this predefined analysis were preterm delivery and low birth weight. Results: The overall prevalence of low birthweight infants and preterm delivery was 10% (371/3851) and 4% (159/3862), respectively. Mothers aged â€16â
years showed higher risk for the delivery of a low birthweight infant (OR: 1.96; 95% CI 1.35 to 2.83). Similarly, preterm delivery was associated with young maternal age (â€16â
years; OR: 2.62; 95% CI 1.59 to 4.30). In a subanalysis restricted to primiparous women: preterm delivery, OR 4.28; 95% CI 2.05 to 8.93; low birth weight, OR: 1.29; 95% CI 0.82 to 2.01. Conclusions: Young maternal age increases the risk for adverse pregnancy outcomes and it is a stronger predictor for low birth weight and preterm delivery than other established risk factors in sub-Saharan Africa. This finding highlights the need to improve adolescent reproductive health in sub-Saharan Africa
- âŠ